Classification of Aβ State From Brain Amyloid PET Images Using Machine Learning Algorithm.

Algorithms Amyloid PET Scan Supervised Machine Learning

Journal

Dementia and neurocognitive disorders
ISSN: 2384-0757
Titre abrégé: Dement Neurocogn Disord
Pays: Korea (South)
ID NLM: 101600298

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 29 03 2023
revised: 19 04 2023
accepted: 23 04 2023
pubmed: 14 5 2023
medline: 14 5 2023
entrez: 14 5 2023
Statut: ppublish

Résumé

Analyzing brain amyloid positron emission tomography (PET) images to access the occurrence of β-amyloid (Aβ) deposition in Alzheimer's patients requires much time and effort from physicians, while the variation of each interpreter may differ. For these reasons, a machine learning model was developed using a convolutional neural network (CNN) as an objective decision to classify the Aβ positive and Aβ negative status from brain amyloid PET images. A total of 7,344 PET images of 144 subjects were used in this study. The 18F-florbetaben PET was administered to all participants, and the criteria for differentiating Aβ positive and Aβ negative state was based on brain amyloid plaque load score (BAPL) that depended on the visual assessment of PET images by the physicians. We applied the CNN algorithm trained in batches of 51 PET images per subject directory from 2 classes: Aβ positive and Aβ negative states, based on the BAPL scores. The binary classification of the model average performance matrices was evaluated after 40 epochs of three trials based on test datasets. The model accuracy for classifying Aβ positivity and Aβ negativity was (95.00±0.02) in the test dataset. The sensitivity and specificity were (96.00±0.02) and (94.00±0.02), respectively, with an area under the curve of (87.00±0.03). Based on this study, the designed CNN model has the potential to be used clinically to screen amyloid PET images.

Sections du résumé

Background and Purpose UNASSIGNED
Analyzing brain amyloid positron emission tomography (PET) images to access the occurrence of β-amyloid (Aβ) deposition in Alzheimer's patients requires much time and effort from physicians, while the variation of each interpreter may differ. For these reasons, a machine learning model was developed using a convolutional neural network (CNN) as an objective decision to classify the Aβ positive and Aβ negative status from brain amyloid PET images.
Methods UNASSIGNED
A total of 7,344 PET images of 144 subjects were used in this study. The 18F-florbetaben PET was administered to all participants, and the criteria for differentiating Aβ positive and Aβ negative state was based on brain amyloid plaque load score (BAPL) that depended on the visual assessment of PET images by the physicians. We applied the CNN algorithm trained in batches of 51 PET images per subject directory from 2 classes: Aβ positive and Aβ negative states, based on the BAPL scores.
Results UNASSIGNED
The binary classification of the model average performance matrices was evaluated after 40 epochs of three trials based on test datasets. The model accuracy for classifying Aβ positivity and Aβ negativity was (95.00±0.02) in the test dataset. The sensitivity and specificity were (96.00±0.02) and (94.00±0.02), respectively, with an area under the curve of (87.00±0.03).
Conclusions UNASSIGNED
Based on this study, the designed CNN model has the potential to be used clinically to screen amyloid PET images.

Identifiants

pubmed: 37179688
doi: 10.12779/dnd.2023.22.2.61
pmc: PMC10166673
doi:

Types de publication

Journal Article

Langues

eng

Pagination

61-68

Informations de copyright

© 2023 Korean Dementia Association.

Déclaration de conflit d'intérêts

Conflict of Interest: The authors have no financial conflicts of interest.

Auteurs

Chanda Simfukwe (C)

Department of Neurology, Chung-Ang University College of Medicine, Seoul, Korea.

Reeree Lee (R)

Department of Nuclear Medicine, Chung-Ang University College of Medicine, Seoul, Korea.

Young Chul Youn (YC)

Department of Neurology, Chung-Ang University College of Medicine, Seoul, Korea.

Classifications MeSH